Replies to post #10827 on OncoSec Medical Inc (ONCSQ)

[lasers]

Yes it would be major news/progress. With sufficient numbers of persons statistically the data could be presented as TLD Peer Review in 2H2014. Phase1/2A of approx. +10 to 15 persons would be meaningful. For rare orphan diseases such a MCC as small as 7 persons could be considered statistically important. $ONCS has considerable opportunity for their MCC and CTCL interim data in 2H2014.